Also trades as: COLO-B.CO (CPH) · $vol 22M · CLPBY (OTC) · $vol 2M · CBHD.DE (XETRA) · $vol 0M

$62.81

+0.00 (+0.00%)

OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 43 · $13.0B mcap · 143M float · 0.0009% daily turnover · Short 90% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$27.8B +2.9% ▲

5Y CAGR: +8.5%

Gross Profit

$18.1B -0.9% ▼

5Y CAGR: +7.5%

Operating Income

$7.6B +3.3% ▲

5Y CAGR: +5.3%

Net Income

$3.6B -28.2% ▼

5Y CAGR: -2.9%

EPS (Diluted)

$16.10 -28.3% ▼

5Y CAGR: -3.9%

EBITDA

$8.3B -1.9% ▼

5Y CAGR: +5.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$19.4B	$22.6B	$24.5B	$27.0B	$27.8B
YoY Growth	+4.8%	+16.2%	+8.5%	+10.3%	+2.9%
Cost of Revenue	$6.1B	$7.0B	$8.2B	$8.8B	$9.7B
Gross Profit	$13.3B	$15.5B	$16.3B	$18.3B	$18.1B
Gross Margin	68.5%	68.8%	66.6%	67.6%	65.1%
R&D Expenses	$755M	$866M	$872M	$913M	$898M
SG&A Expenses	$6.2B	$7.8B	$8.6B	$10.1B	$9.6B
Operating Expenses	$7.0B	$8.6B	$9.6B	$10.9B	$10.5B
Operating Income	$6.4B	$6.4B	$6.8B	$7.3B	$7.6B
Operating Margin	32.7%	28.5%	27.6%	27.1%	27.2%
Interest Expense	$25M	$172M	$638M	$795M	$823M
Income Before Tax	$6.2B	$6.1B	$6.0B	$6.4B	$6.1B
Tax Expense	$1.4B	$1.4B	$1.2B	$1.3B	$2.5B
Net Income	$4.8B	$4.7B	$4.8B	$5.1B	$3.6B
Net Margin	24.8%	20.8%	19.5%	18.7%	13.0%
EPS (Diluted)	$22.63	$22.11	$22.19	$22.46	$16.10
EBITDA	$7.0B	$7.2B	$7.7B	$8.5B	$8.3B
Shares Outstanding	213M	213M	216M	225M	225M

Line Item	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$7.0B	$7.0B	$6.9B	$7.0B	$6.9B	$7.0B	$7.1B	$7.3B
Cost of Revenue	$2.3B	$2.3B	$2.2B	$2.3B	$2.2B	$2.3B	$4.0B	$2.4B
Gross Profit	$4.6B	$4.8B	$4.7B	$4.7B	$4.8B	$4.7B	$3.0B	$4.9B
Gross Margin	66.7%	67.6%	68.2%	67.6%	68.4%	67.2%	42.9%	66.7%
R&D Expenses	$219M	$219M	$239M	$239M	$249M	$247M	$254M	$280M
SG&A Expenses	$2.6B	$2.6B	$2.6B	$2.6B	$2.6B	$2.6B	$2.7B	$2.7B
Operating Expenses	$2.7B	$2.8B	$2.8B	$2.9B	$2.8B	$2.9B	$1.2B	$3.0B
Operating Income	$1.9B	$1.9B	$1.9B	$1.8B	$1.9B	$1.9B	$1.8B	$1.9B
Operating Margin	27.4%	27.2%	27.3%	26.3%	27.6%	26.3%	25.4%	25.9%
Interest Expense	$193M	$204M	$316M	$490M	$184M	$164M	$135M	$192M
Income Before Tax	$1.6B	$1.8B	$1.5B	$1.3B	$1.6B	$1.8B	-$1.2B	$1.9B
Tax Expense	$289M	$725M	$579M	$537M	$679M	$394M	-$273M	$411M
Net Income	$1.3B	$1.0B	$912M	$805M	$873M	$1.4B	-$972M	$1.5B
Net Margin	18.9%	14.9%	13.2%	11.6%	12.6%	19.8%	-13.7%	19.9%
EPS (Diluted)	$5.84	$4.63	$4.05	$3.57	$3.88	$6.20	$-4.31	$6.47
EBITDA	$2.1B	$2.3B	$2.2B	$2.2B	$2.2B	$2.2B	$5.2B	$2.3B
Shares Outstanding	225M	225M	225M	225M	225M	225M	225M	225M

CLPBF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet